Search Results - "Ponzoni, Mirco"
-
1
Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer
Published in International journal of molecular sciences (04-07-2018)“…Macrophages, cells belonging to the innate immune system, present a high plasticity grade, being able to change their phenotype in response to environmental…”
Get full text
Journal Article -
2
Recent advances in the developmental origin of neuroblastoma: an overview
Published in Journal of experimental & clinical cancer research (11-03-2022)“…Neuroblastoma (NB) is a pediatric tumor that originates from neural crest-derived cells undergoing a defective differentiation due to genomic and epigenetic…”
Get full text
Journal Article -
3
A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors
Published in Oncogene (28-10-2021)“…MYCN drives aggressive behavior and refractoriness to chemotherapy, in several tumors. Since MYCN inactivation in clinical settings is not achievable,…”
Get full text
Journal Article -
4
Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma
Published in Journal of immunology research (01-01-2018)“…Neuroblastoma (NB) and malignant melanoma (MM), tumors of pediatric age and adulthood, respectively, share a common origin, both of them deriving from the…”
Get full text
Journal Article -
5
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A
Published in Molecular therapy (04-01-2017)“…The progression of fibrosis in chronic liver disease is dependent upon hepatic stellate cells (HSCs) transdifferentiating to a myofibroblast-like phenotype…”
Get full text
Journal Article -
6
The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis
Published in Nutrients (24-06-2021)“…Neuroblastoma (NB) is the most common extra-cranial solid tumor of pediatric age. The prognosis for high-risk NB patients remains poor, and new treatment…”
Get full text
Journal Article -
7
Discovery of a novel glucose metabolism in cancer: The role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt
Published in Scientific reports (28-04-2016)“…Cancer metabolism is characterized by an accelerated glycolytic rate facing reduced activity of oxidative phosphorylation. This “Warburg effect” represents a…”
Get full text
Journal Article -
8
Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib
Published in Journal of experimental & clinical cancer research (22-09-2020)“…Abstract Background Despite reported advances, acquired resistance to tyrosine kinase inhibitors still represents a serious problem in successful cancer…”
Get full text
Journal Article -
9
Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling
Published in Molecular oncology (01-11-2021)“…Lung cancer is the leading cause of cancer‐related death worldwide. Late diagnosis and metastatic dissemination contribute to its low survival rate. Since…”
Get full text
Journal Article -
10
Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations
Published in International journal of molecular sciences (01-10-2022)“…Neuroblastoma (NB) is the most common extracranial solid tumor encountered in childhood. Although there has been significant improvement in the outcomes of…”
Get full text
Journal Article -
11
Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors
Published in Pharmaceuticals (Basel, Switzerland) (26-08-2021)“…Retinoids are a class of natural and synthetic compounds derived from vitamin A. They are involved in several biological processes like embryogenesis,…”
Get full text
Journal Article -
12
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
Published in Journal of controlled release (10-08-2015)“…Neuroblastoma is a childhood cancer with poor long-term prognosis in advanced stages. A major aim in neuroblastoma therapy is to develop targeted drug delivery…”
Get full text
Journal Article -
13
Enhancement of Tumor Homing by Chemotherapy‐Loaded Nanoparticles
Published in Small (Weinheim an der Bergstrasse, Germany) (01-11-2018)“…Targeted delivery of anticancer drugs with nanocarriers can reduce side effects and ameliorate therapeutic efficacy. However, poorly perfused and dysfunctional…”
Get full text
Journal Article -
14
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
Published in Journal of experimental & clinical cancer research (02-06-2021)“…Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Nucleolin (NCL) is a protein overexpressed and…”
Get full text
Journal Article -
15
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
Published in Pharmaceuticals (Basel, Switzerland) (28-02-2022)“…Despite improvements in therapies and screening strategies, lung cancer prognosis still remains dismal, especially for metastatic tumors. Cancer stem cells…”
Get full text
Journal Article -
16
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature- specific ligands potentiates therapeutic efficacy
Published in Cancer research (Chicago, Ill.) (15-10-2006)“…Neuroblastoma, the most common solid tumor of infancy derived from the sympathetic nervous system, continues to present a formidable clinical challenge…”
Get full text
Journal Article -
17
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Published in Journal of experimental & clinical cancer research (17-11-2022)“…Abstract Background Poor infiltration of functioning T cells renders tumors unresponsive to checkpoint-blocking immunotherapies. Here, we identified a…”
Get full text
Journal Article -
18
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models
Published in Journal of translational medicine (13-02-2024)“…Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Although the overall survival of patients with NB…”
Get full text
Journal Article -
19
Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma
Published in Journal of controlled release (28-09-2013)“…Neuroblastoma is an embryonal tumor originating from the simpatico-adrenal lineage of the neural crest. It approximately accounts for about 15% of all…”
Get full text
Journal Article -
20
Tumor Regression and Curability of Preclinical Neuroblastoma Models by PEGylated SN38 (EZN-2208), a Novel Topoisomerase I Inhibitor
Published in Clinical cancer research (01-10-2010)“…Treatment of neuroblastoma is successful in less than half of patients with high-risk disease. The antitumor activity of a water soluble pegylated SN38 drug…”
Get full text
Journal Article